Epidemiology, Risk Factors, and Management of Biphasic Anaphylaxis

被引:0
作者
Giannetti, Matthew P. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Allergy & Clin Immunol, 60 Fenwood Rd,Hale Bldg Transformat Med,5 Floor, Boston, MA 02132 USA
[2] Harvard Med Sch, Boston, MA 02132 USA
关键词
Anaphylaxis; Biphasic anaphylaxis; Tryptase; Mast cell; EMERGENCY-DEPARTMENT PATIENTS; PRACTICE PARAMETER UPDATE; NATIONAL INSTITUTE; RECOGNITION; EPINEPHRINE; SEVERITY; CHILDREN; ALLERGY;
D O I
10.1007/s11882-024-01179-1
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of ReviewBiphasic anaphylaxis is a variant of anaphylaxis characterized by recurrence of symptoms after initial resolution of anaphylaxis. It was first described in the mid 1990s by Popa and Lerner. Our understanding of the pathophysiology and epidemiology of the condition has advanced considerably since then. The purpose of this manuscript is to review the literature surrounding biphasic anaphylaxis while highlighting key works and recent advances.Recent FindingsPrior studies have estimated biphasic anaphylaxis occurs in 0.4-20% of anaphylaxis episodes. The wide range may be related to differences in anaphylaxis diagnostic criteria which was inconsistent across studies. Recently identified risk factors for occurrence of biphasic anaphylaxis include severe initial symptoms including hypotension or hypoxia, delay in epinephrine use, and greater than one dose of epinephrine required to treat symptoms.SummaryDespite our progress to better understand biphasic anaphylaxis, there remain gaps in the literature. This article aims to review the recent literature including, epidemiology, risk factors, and management of biphasic anaphylaxis.
引用
收藏
页码:651 / 656
页数:6
相关论文
共 50 条
  • [31] Management of Anaphylaxis in Infants and Toddlers
    Ramsey, Nicole
    Wang, Julie
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (01) : 77 - 90
  • [32] Management of anaphylaxis in the emergency setting
    Worth, Allison
    Soar, Jasmeet
    Sheikh, Aziz
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (01) : 89 - 100
  • [33] Epidemiology of anaphylaxis
    Tejedor Alonso, M. A.
    Moro Moro, M.
    Mugica Garcia, M. V.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2015, 45 (06) : 1027 - 1039
  • [34] Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals
    Clark, Sunday
    Wei, Wenhui
    Rudders, Susan A.
    Camargo, Carlos A., Jr.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (05) : 1125 - 1130
  • [35] Risk factors for anaphylaxis and severe reactions
    Worm, M.
    Doelle, S.
    Nassiri, M.
    Babina, M.
    ALLERGOLOGIE, 2014, 37 (07) : 251 - 257
  • [36] Risk factors for anaphylaxis in patients with mastocytosis
    Gorska, Aleksandra
    Niedoszytko, Marek
    Lange, Magdalena
    Chelminska, Marta
    Nedoszytko, Boguslaw
    Wasag, Bartosz
    Slominski, Jan Marek
    Gruchala-Niedoszytko, Marta
    Nowicki, Roman
    Jassem, Ewa
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (1-2): : 46 - 53
  • [37] Risk Factors for Severe Anaphylaxis in Children
    Olabarri, Mikel
    Vazquez, Paula
    Gonzalez-Posada, Aranzazu
    Sanz, Nuria
    Gonzalez-Peris, Sebastia
    Diez, Nuria
    Vinuesa, Ana
    Martinez-Indart, Lorea
    Benito, Javier
    Mintegi, Santiago
    JOURNAL OF PEDIATRICS, 2020, 225 : 193 - +
  • [38] Anaphylaxis mortality in the perioperative setting: Epidemiology, elicitors, risk factors and knowledge gaps
    Pouessel, Guillaume
    Tacquard, Charles
    Tanno, Luciana Kase
    Mertes, Paul Michel
    Lezmi, Guillaume
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (01) : 11 - 20
  • [39] mRNA COVID-19 Vaccine Anaphylaxis: Epidemiology, Risk Factors, and Evaluation
    Jordon Jaggers
    Anna R. Wolfson
    Current Allergy and Asthma Reports, 2023, 23 : 195 - 200
  • [40] Critical Care Management of the Patient With Anaphylaxis: A Concise Definitive Review
    Krishnaswamy, Guha
    CRITICAL CARE MEDICINE, 2021, 49 (05) : 838 - 857